A new study from #ILLINOIS researchers found that patients with ER-positive breast cancer who lived in disadvantaged neighborhoods showed higher levels of inflammation- and stress-related biomarkers compared with those in more affluent areas. 🔗 https://t.co/hDL4a9CfYb

New findings from #ILLINOIS researchers show that a small molecule in our DNA (called snaR-A) could drive cancer growth. 🔗 https://t.co/CLoejj52lP

#ILLINOIS researchers have developed a simpler and faster way to build DNA nanostructures, allowing them to perform better in biological environments. CCIL member Xing Wang has used DNA nanostructures targeted cancer drug delivery. 🔗 https://t.co/LqeoFbu15D

November is #LungCancerAwarenessMonth A team led by CCIL researchers is improving an imaging system used in bronchoscopy procedures to find small lung nodules. Their new camera has improved the system's imaging sensitivity by 10 times. 🔗 https://t.co/HZ3jVH76lP

💡 NEW DISCOVERY: Researchers have found that a naturally occurring protein boosts the effectiveness of certain breast cancer treatments, helping with the rupture of cancer cells. 🔗 https://t.co/BsYI64rmOJ

NEW: #ILLINOIS researchers have discovered a communication pathway that helps breast cancer spread. The team will now work on developing treatment strategies that disrupt the pathway, with a goal of preventing metastasis. 🔗 https://t.co/L6hSQxecD7

NEW OPPORTUNITY: The CCIL introduces the Cancer Education Undergraduate Certificate! This certificate program is open to undergraduate students who demonstrate a sustained commitment to cancer education through learning, outreach, and research. 🔗 https://t.co/Yeah5Unzpl

EMPOWERING STUDENT RESEARCHERS 🔶🔷 Ph.D. student Rana Abbed is researching breast and ovarian cancers. The Deborah M. House Fund for Cancer Research recently supported Abbed’s work through a collaboration with Siteman Cancer Center. 🔗 https://t.co/eCopfAHLdd

Researchers at #ILLINOIS have developed a way to track chemotherapy drugs inside of cancer cells. This ground-breaking research focuses on a transformed version of a widely used chemotherapy drug, doxorubicin, which makes the drug detectable. 🔗 https://t.co/eWWQlG3EC6

New research from #ILLINOIS shows that measuring a key hormone could help predict fertility outcomes for women with cancer who choose fertility preservation. 🔗 https://t.co/kPJLQOwGJp

SCIENCE IN ACTION🔬 10 students from #ILLINOIS presented at the 2025 International Cancer Education Conference, a national forum that brings together researchers, educators, health professionals, and students. Congratulations to all who presented! 🎉 🔗 https://t.co/Y1LpSaNQPt

#ILLINOIS researchers have developed a model that uses a patient's blood to predict how likely they are to respond to immune checkpoint blockade drugs, a type of immunotherapy treatment. 🔗 https://t.co/9hhHhvcniY

🎥 IN THE NEWS: Breast Cancer Awareness Month 💗 CCIL researcher Michael Oelze shared his ultrasound technology research with @WCIA 3 News, highlighting the ways it holds potential to help patients. 🔗 https://t.co/Jszsu5NlhG

#ILLINOIS researchers are developing technology that will make sure tumor tissue and cells are completely removed during surgery. 🔗 The principal investigator is reflecting on what the team has accomplished in the first year of a five-year project: https://t.co/FuJhGiYLml

New federal grants totaling $2.6 million will support CCIL researcher Michael Oelze's efforts to solve problems with existing ultrasound technologies and increase accessibility to new breakthroughs in the field. 🔗 https://t.co/sJsIT5s7Ek

The Cancer Voices Project is designed to capture the perspectives of people who experience cancer - from patients and survivors to family members and doctors. 📣 The team is collecting interviews through the end of THIS MONTH. 🔗 https://t.co/DDlPLYEMaS

In a recent study, #ILLINOIS researchers identified how PFAS disrupt cells and found a way to repair them. The team is now collaborating with surgeons to identify patients with a higher risk of developing kidney cancer based on PFAS levels. 🔗 https://t.co/dlCw5iwPmL

CCIL Distinguished Lecture Series 📆 October 8 | 1 - 2 p.m. 📍NCSA 1040 or Teams ▶ Speaker: Elaine Fuchs 🔗 Registration required: https://t.co/HuAkkuFN9I

Illinois researchers have developed a new method that could drastically accelerate the development of antibody-based treatments, immune therapies, and vaccines for various diseases, including cancer. 🔗 https://t.co/m3ZGTvuU0B

#ILLINOIS researchers have developed a framework for understanding and controlling the flow behavior of granular hydrogels — a material that mimics the mechanical properties of living tissue and holds potential for use in medicine and tissue repair. 🔗 https://t.co/v8bI6vDO4C